(RTTNews) – Nektar Therapeutics (NKTR) introduced Friday the marketing of Jillian Thomsen to Senior Vice President (SVP) & Main Financial Officer. Thomsen has served as SVP, Finance & Chief Accounting Officer of Nektar since 2008, and is a essential member of the Govt Committee.
Gil Labrucherie, the company’s current Main Operating Officer & Chief Monetary Officer, will be departing the corporation to pursue yet another opportunity at a non-public biotechnology firm.
In April 2008, Thomsen was appointed Chief Accounting Officer at Nektar and joined the Executive Committee. She has in excess of 30 years of finance and accounting practical experience.
In her recent purpose, Thomsen oversees accounting, economic reporting, FP&A, Sarbanes-Oxley compliance, treasury, tax, medical outsourcing, and procurement capabilities at the firm. From 2006 to 2008, she served as Vice President, Finance and Controller of Nektar.
Prior to joining Nektar in 2006, Thomsen was Deputy Controller of Calpine Corp. from September 2002 to February 2006.
The views and opinions expressed herein are the views and thoughts of the writer and do not necessarily replicate these of Nasdaq, Inc.
Resource website link